Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy
T Sauerer, GF Velázquez, C Schmid - Molecular Cancer, 2023 - Springer
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by the expansion
of immature myeloid cells in the bone marrow (BM) and peripheral blood (PB) resulting in …
of immature myeloid cells in the bone marrow (BM) and peripheral blood (PB) resulting in …
[PDF][PDF] 靶向治疗及免疫治疗时代造血干细胞移植在急性白血病中的应用
姜尔烈， 郑亚伟 - 临床血液学杂志, 2023 - lcxy.whuhzzs.com
目前造血干细胞移植已成为急性白血病治疗中不可或缺的组成部分. 虽然过去20
年来靶向治疗及免疫治疗迅速发展, 提高了急性白血病的疗效, 但造血干细胞移植的治疗地位 …
年来靶向治疗及免疫治疗迅速发展, 提高了急性白血病的疗效, 但造血干细胞移植的治疗地位 …
Advances in second hematopoietic stem cell transplantation
S Yan, X Zhu, Y Xiao - Frontiers in Immunology, 2024 - frontiersin.org
Hematopoietic stem cell transplantation (HSCT) is a widely used treatment for malignant
hematological diseases; however, some patients inevitably experience relapse. Therefore …
hematological diseases; however, some patients inevitably experience relapse. Therefore …
How risky is a second allogeneic stem cell transplantation?
O Penack, M Abouqateb, C Peczynski, W Boreland… - Leukemia, 2024 - nature.com
There is no consensus on second allogeneic stem cell transplantation (alloSCT) indications
in patients with hematologic malignancies relapsing after a first alloSCT. In historic …
in patients with hematologic malignancies relapsing after a first alloSCT. In historic …
Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 …
AK Schmälter, M Ngoya, JE Galimard… - Blood Cancer …, 2024 - nature.com
Second allogeneic stem cell transplantation (alloSCT2) is among the most effective
treatments for acute myeloid leukemia (AML) relapse after first alloSCT (alloSCT1). Long …
treatments for acute myeloid leukemia (AML) relapse after first alloSCT (alloSCT1). Long …
Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia-a retrospective analysis of 1540 …
Second allogeneic stem cell transplantation (alloSCT2) is an increasingly used treatment for
acute myeloid leukemia relapsing after first alloSCT. The scope of this study was to analyze …
acute myeloid leukemia relapsing after first alloSCT. The scope of this study was to analyze …
Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia-an EBMT registry analysis of 1540 …
C Schmid, AK Schmaelter, M Ngoya, JE Galimard… - 2024 - researchsquare.com
Second allogeneic stem cell transplantation (alloSCT2) is among the most effective
treatments for acute myeloid leukemia (AML) relapse after first alloSCT (alloSCT1). Long …
treatments for acute myeloid leukemia (AML) relapse after first alloSCT (alloSCT1). Long …
Hematopoietic stem cell transplantation for acute leukemia in the era of targeted therapies and immunotherapy
J Erlie, Z Yawei - J Clin Hematol, 2023 - lcxyen.whuhzzs.com
Hematopoietic stem cell transplantation (HSCT) is an integral therapy in the treatment of
acute leukemia. In the last 2 decades, novel targeted therapies and immunotherapies have …
acute leukemia. In the last 2 decades, novel targeted therapies and immunotherapies have …